Phase I trial of AKB 9778 in healthy volunteers.

Trial Profile

Phase I trial of AKB 9778 in healthy volunteers.

Phase of Trial: Phase I

Latest Information Update: 20 Mar 2012

At a glance

  • Drugs AKB 9778 (Primary)
  • Indications Diabetic macular oedema
  • Focus Adverse reactions; Pharmacokinetics
  • Most Recent Events

    • 20 Mar 2012 Positive safety, pharmacokinetic and pharmacodynamic results were reported in an Aerpio media release
    • 20 Mar 2012 Status changed from recruiting to completed, according to an Aerpio media release.
    • 13 Jan 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top